Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis

Anti‐diabetic agent‐related hypoglycemia is a serious complication in type 2 diabetic patients on hemodialysis. Therefore, we assessed the efficacy and tolerability of 24 weeks of monotherapy with vildagliptin, a dipeptidyl peptidase four inhibitor, which is a new class of antidiabetic agent. This o...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kume, Shinji, Uzu, Takashi, Takagi, Chieko, Kondo, Morihiro, Okabe, Tomoko, Araki, Shin‐ichi, Isshiki, Keiji, Takeda, Naoko, Kondo, Keiko, Haneda, Masakazu, Koya, Daisuke, Nishio, Yoshihiko, Kashiwagi, Atsunori, Maegawa, Hiroshi
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2012
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4014953/
https://ncbi.nlm.nih.gov/pubmed/24843580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2011.00169.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki